Erythrocyte Fate after Subarachnoid Haemorrhage: Compartmental Redistribution, Cellular Processing, and Erythrolysis
Translational Stroke Research · 2026-12 · 17 (6)
DOI: 10.1007/s12975-026-01514-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Stroke Research, online erschienen am 06.11.2026. Verfasst von Meng Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Erythrocytes. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Science and Technology Program of the Xizang Autonomous Region.
Abstract (Originalsprache)
Subarachnoid haemorrhage (SAH) introduces a large erythrocyte burden into the subarachnoid space (SAS) and cerebrospinal fluid (CSF). Most mechanistic studies have focused on events after erythrocyte lysis, when cell-free haemoglobin (Hb), haem, iron, and other erythrocyte-derived mediators promote vascular dysfunction, oxidative injury, and inflammation. Before membrane rupture, however, erythrocytes can remain within clot or CSF, undergo transport towards extracranial drainage pathways, or become associated with and internalised by local cells. Evidence from human CSF studies, experimental SAH models, and other haemorrhagic brain injury models indicates that these processes involve heterogeneous erythrocyte populations and need not occur in a fixed sequence. We propose that the erythrocyte burden after SAH is dynamically partitioned among retained cellular, extracranially transported, cell-associated, and extracellular molecular pools. The biological consequences of this redistribution depend on both the rate of transfer between pools and whether lymphatic, phagocytic, haemoglobin-binding, haem-processing, and iron-storage systems become capacity-limited. This framework distinguishes direct evidence from mechanistic inference and generates testable predictions about when erythrocyte removal, cellular uptake, or molecular scavenging will reduce injury rather than redistribute it. Defining erythrocyte fate quantitatively may identify therapeutic opportunities both before and after extracellular erythrolysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
- NHC Key Laboratory of Clinical Epidemiology and Evidence-based Medicine, West China Hospital, Sichuan University, Chengdu, China.
- Department of Neurosurgery, Lanzhou University Second Hospital, Lanzhou, China.
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. zhangcw1976@126.com.
Förderung
- Science and Technology Program of the Xizang Autonomous Region
Zitieren
APA
Ji, M., Ma, Y. H., Hu, H. T., Wang, T., Shang, R., Liu, K., & Zhang, C. W. (2026). Erythrocyte Fate after Subarachnoid Haemorrhage: Compartmental Redistribution, Cellular Processing, and Erythrolysis. Translational Stroke Research, 17(6). https://doi.org/10.1007/s12975-026-01514-w
Vancouver
Ji M, Ma YH, Hu HT, Wang T, Shang R, Liu K, et al. Erythrocyte Fate after Subarachnoid Haemorrhage: Compartmental Redistribution, Cellular Processing, and Erythrolysis. Translational Stroke Research. 2026;17(6). doi:10.1007/s12975-026-01514-w
BibTeX
@article{Ji2026,
author = {Ji, Meng and Ma, Yu-Hu and Hu, Hai-Tao and Wang, Ting and Shang, Rui and Liu, Kai and Zhang, Chang-Wei},
title = {Erythrocyte Fate after Subarachnoid Haemorrhage: Compartmental Redistribution, Cellular Processing, and Erythrolysis},
journal = {Translational Stroke Research},
year = {2026},
volume = {17},
number = {6},
doi = {10.1007/s12975-026-01514-w}
}
EUVIMED